The effect of HMG-CoA reductase inhibitor on glucose tolerance and insulin sensitivity in type 2 diabetes mellitus animal model

被引：0
|
作者：
Kwon, Hyuk-Sang
Hong, Oak-Kee
Ko, Seung-Hyun
Choi, Yoon-Hee
Lee, Sung-Soo
Son, Tae-Seo
Moon, Sung-Dae
Yoo, Soon-Jib
Son, Hyun-Sik
Yoon, Kun-Ho
Cha, Bong-Yun
Son, Ho-Young
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [1] The effect of HMG-CoA reductase inhibitor on glucose tolerance and insulin sensitivity in type 2 diabetes mellitus animal model
    Kwon, H. -S.
    Hong, O. -K.
    Ko, S. -H.
    Choi, Y. -H.
    Lee, S. -S.
    Son, T. -S.
    Moon, S. -D.
    Yoo, S. -J.
    Son, H. -S.
    Yoon, K. -H.
    Cha, B. -Y.
    Son, H. -Y.
    DIABETOLOGIA, 2006, 49 : 370 - 370
  • [2] Mechanisms underlying recoupling of enos by HMG-COA reductase inhibition in an animal model of diabetes mellitus
    Brandt, M.
    Wenzel, P.
    Daiber, A.
    Ocize, M.
    Closs, E.
    Xu, J.
    Thum, T.
    Baucrsachs, J.
    Ertl, G.
    Zou, M. -H.
    Foerstermann, U.
    Muenzel, T.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 64 - 64
  • [3] HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
    Chung, YS
    Lee, MD
    Lee, SK
    Kim, HM
    Fitzpatrick, LA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1137 - 1142
  • [4] Effectiveness of pitavastatin, an HMG-CoA reductase inhibitor, on lipid and glucose metabolism in Japanese patients with type 2 diabetes
    Kawai, Toshihide
    Tokui, Mikiya
    Funae, Osamu
    Meguro, Shu
    Yamada, Satoru
    Tabata, Mitsuhisa
    Shimada, Akira
    DIABETES, 2006, 55 : A461 - A461
  • [5] Efficacy of pitavastatin, a new HMG-CoA reductase inhibitor, on lipid and glucose metabolism in patients with type 2 diabetes
    Kawai, T
    Tokui, M
    Funae, O
    Meguro, S
    Yamada, S
    Tabata, M
    Shimada, A
    DIABETES CARE, 2005, 28 (12) : 2980 - 2981
  • [6] TOWARDS A NEW TYPE OF HMG-COA REDUCTASE INHIBITOR
    BARTH, M
    BELLAMY, FD
    RENAUT, P
    SAMRETH, S
    SCHUBER, F
    TETRAHEDRON, 1990, 46 (19) : 6731 - 6740
  • [7] HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus
    Nakashima, A
    Nakashima, R
    Ito, T
    Masaki, T
    Yorioka, N
    DIABETIC MEDICINE, 2004, 21 (09) : 1020 - 1024
  • [8] Inhibition of HMG-CoA reductase with cerivastabin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus
    Scharnagl, H
    Winkler, K
    Mantz, S
    Baumstark, MW
    Wieland, H
    März, W
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (05) : 269 - 277
  • [9] HMG-CoA reductase inhibitors prevent bone loss in patients with type 2 diabetes mellitus.
    Nakashima, A
    Nakashima, R
    Masaki, T
    Harada, S
    Yorioka, N
    DIABETES, 2003, 52 : A128 - A128
  • [10] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Doh, Fa Mee
    Chang, Tae-Ik
    Koo, Hyang Mo
    Lee, Mi Jung
    Shin, Dong Ho
    Kim, Chan Ho
    Ko, Kwang Il
    Oh, Hyung Jung
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Han, Dae-Suk
    Han, Seung Hyeok
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (06) : 501 - 509
12345